These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22668652)

  • 1. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
    Idorn L; Vissing NH; Jensen L; Herlin T
    Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muckle-Wells treatment with anakinra.
    Eungdamrong J; Boyd KP; Meehan SA; Latkowski JA
    Dermatol Online J; 2013 Dec; 19(12):20720. PubMed ID: 24365011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous neutrophils infiltrates. Case 8. CINCA/NOMID syndrome].
    Fraitag S
    Ann Pathol; 2011 Jun; 31(3):203-7. PubMed ID: 21737003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.
    Kolivras A; Theunis A; Ferster A; Lipsker D; Sass U; Dussart A; André J
    J Cutan Pathol; 2011 Feb; 38(2):202-8. PubMed ID: 21062341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
    Goldbach-Mansky R
    Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty year follow up of a patient with a new de-novo NLRP3 mutation (S595G) and CINCA syndrome.
    Kanariou M; Dracou C; Spanou K; Möller J; Rösen-Wolff A; Schuster V; Roesler J
    Klin Padiatr; 2009; 221(6):379-81. PubMed ID: 19890791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
    Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
    Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review.
    Finetti M; Omenetti A; Federici S; Caorsi R; Gattorno M
    Orphanet J Rare Dis; 2016 Dec; 11(1):167. PubMed ID: 27927236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exacerbation of skin lesions during fever in a patient with chronic infantile neurologic cutaneous articular (CINCA) syndrome].
    Aboín-González S; Aldanondo-Fernández de la Mora I; García-Acebes CR; Carrillo-Gijón R; Harto-Castaño A; Jaén-Olasolo P
    Actas Dermosifiliogr; 2008; 99(6):481-4. PubMed ID: 18558058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
    Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
    Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal urticaria: Could it be CAPS?
    Cutts L; Parslew R; Eustace K
    Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

  • 19. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
    Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
    Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist].
    Rameev VV; Kozlovskaia LV; Bogdanova MV
    Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.